Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

976
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
976
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

864
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
864
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

942
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
942
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.4K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

855
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
855

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meta-Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.

Alimentary pharmacology & therapeutics·2026
Same author

Editorial: Bodily Maps of Emotions in Irritable Bowel Syndrome-Implications for Brain-Gut and Gut-Brain Interventions.

Neurogastroenterology and motility·2026
Same author

How I Approach Refractory Constipation Symptoms.

The American journal of gastroenterology·2026
Same author

Recommendations for the Evaluation and Management of Inflammatory Bowel Disease With Irritable Bowel Syndrome-Like Symptoms: A Joint Rome Foundation and International Organization for the Study of IBD (IOIBD) Consensus.

Gastroenterology·2026
Same author

Biopsychosocial Aspects of Adult and Pediatric Disorders of Gut-Brain Interaction.

Gastroenterology·2026
Same author

Oral Vancomycin Is an Effective Therapy in Adult Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.

Gastro hep advances·2026

Related Experiment Video

Updated: Mar 1, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.7K

Considering the Bidirectional Pathways Between Depression and IBD: Recommendations for Comprehensive IBD Care.

Laurie Keefer1, Sunanda V Kane1

  • 1Dr Keefer is the director of Psychobehavioral Research at the Icahn School of Medicine at Mount Sinai in New York, New York. She is also codirector of the IBD Home at the Susan and Leonard Feinstein IBD Center at the Mount Sinai Hospital in New York, New York. Dr Kane is a professor of medicine in the Department of Gastroenterology and Hepatology at the Mayo Clinic College of Medicine in Rochester, Minnesota.

Gastroenterology & Hepatology
|May 26, 2017
PubMed
Summary

Patients with inflammatory bowel disease (IBD) face higher depression risks due to chronic illness and bidirectional disease-inflammation links. Addressing depression is crucial for effective IBD management and patient well-being.

Keywords:
Depressioncognitive behavioral therapycopinginflammatory bowel disease

More Related Videos

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

544
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

677

Related Experiment Videos

Last Updated: Mar 1, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.7K
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

544
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

677

Area of Science:

  • Gastroenterology
  • Psychiatry
  • Chronic Disease Management

Background:

  • Inflammatory bowel disease (IBD) patients experience increased mental health issues, particularly depression, due to disease chronicity.
  • The relationship between IBD and depression is bidirectional: poor health impacts self-management and vice versa, while inflammation influences and is influenced by depression.
  • Historically, depression in IBD populations has been undertreated, posing risks to patient health and healthcare systems.

Purpose of the Study:

  • To explore the bidirectional relationship between inflammatory bowel disease (IBD) and depression.
  • To highlight the underdiagnosis and undertreatment of depression in IBD patients.
  • To provide recommendations for assessing and treating depression within the context of IBD.

Main Methods:

  • Literature review and synthesis of current research on IBD and depression.
  • Analysis of the bidirectional pathways linking inflammation, disease activity, and depressive symptoms.
  • Discussion of clinical implications for patient care.

Main Results:

  • Evidence supports a two-way interaction between IBD and depression, involving self-management behaviors and inflammatory processes.
  • Depression significantly complicates IBD management and impacts patient quality of life.
  • Current treatment paradigms often fail to adequately address the psychological burden of IBD.

Conclusions:

  • Integrated care models are needed to address the complex interplay between IBD and depression.
  • Early and consistent screening for depression in IBD patients is essential.
  • Tailored treatment strategies addressing both gastrointestinal and psychological symptoms are critical for improving outcomes in inflammatory bowel disease.